Trial Profile
Diabetes Therapy to Improve BMI and Lung Function in CF.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 01 Nov 2019
Price :
$35
*
At a glance
- Drugs Insulin aspart (Primary) ; Repaglinide (Primary)
- Indications Diabetes mellitus
- Focus Pharmacodynamics
- Acronyms CFRDT
- 09 Nov 2009 New trial record.
- 09 Nov 2009 New trial record.
- 01 Oct 2009 Results were published in Diabetes Care.